Delayed Initiation of ECMO is Associated With Poor Prognosis in Severe COVID-19 Patients: A Multicenter Retrospective Cohort Study
Social Science Research Network(2021)
Abstract
Background: Extracorporeal membrane oxygenation (ECMO) is a rapidly evolving therapy for acute lung and/or heart failure. However, information on the application of ECMO in severe coronavirus disease 2019 (COVID-19) is limited, such as the initiation time, especially in the ECMO instrument shortages period and regions, not all the listed patients could be treated with ECMO in time. This study aims to investigate and clear the timing of ECMO initiation related to the prognosis of severe COVID-19 patients. And emphasize the initiation time of ECOM application no more than 24 hours, when the ECMO completion trigger is tripped.
Methods: In this retrospective, multi-center cohort study, we enrolled all ECMO patients with confirmed COVID-19 at three hospitals between Dec 29, 2019 and Apr 5, 2020. Demographic data, clinical presentation, laboratory profile, clinical course, treatments, complications and outcomes were collected. The primary outcomes were analyzed by ECMO weaning rate and 60-day mortality after ECMO.
Results: A total of 31 patients were included in the analysis, 60-day mortality rate after ECMO was 71% and ECMO weaning rate was 26%. Due to ECMO instrument shortages, patients were divided into delayed ECMO groups (3 [IQR, 2-5] days) and early ECMO groups (0.5 [IQR, 0-1] days) based on the initiation time of ECMO. There were 14 patients in the early treatment group and 17 patients in the delayed group. Early initiation of ECMO was associated with decreased 60-day mortality after ECMO (50% vs. 88%, P=0.044) and increased ECMO weaning rate (50% vs. 6%, P=0.011).
Conclusions: In the ECMO supported COVID-19 patients, delayed initiation of ECMO is a risk factor and associated with a poorer prognosis for these patients.
Trial Registration: Chinese Clinical Trial Registry identifier: ChiCTR2000030947.
Funding Statement: Not applicable.
Declaration of Interests: The authors declare that they have no competing interests.
Ethics Approval Statement: The study was approved by Jinyintan Hospital ethics board.
MoreTranslated text
Key words
ecmo,poor prognosis
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined